Literature DB >> 18778947

Changes in quality of life, physical activity, and symptomatic status one year after myocardial revascularization for stable angina.

Athanasios L P Markou1, Armand van der Windt, Henri A van Swieten, Luc Noyez.   

Abstract

BACKGROUND: This study investigates changes of quality of life (QOL), physical activity (PA) and symptomatic status (NYHA) at one-year post-coronary artery bypass grafting (CABG).
METHODS: Of 568 patients undergoing a primary isolated CABG for stable angina (NYHA <IV) pre- and 1-year postoperative data on QOL, PA, and NYHA were complete. Studied outcomes were changes in QOL, EuroQoL questionnaire, PA, the Corpus Christi Heart Project criteria and NYHA. Analysis was based on three age groups. Group A, age <65 years: 285 patients, group B, 65-74 years: 210 patients, and group C, age >or=75 years: 73 patients.
RESULTS: There is a similar, significant decrease of NYHA class (1.4) for the three groups (p<0.0005). An overall significant improvement for QOL and PA is however different in the three subgroups. PA improvement is not significant in group C (p=0.74), significant in group B (p=0.005) and in group A (p<0.0005). For the QOL, group A shows a significant improvement for the five different domains, group B for two, and group C only for one domain. The visual analogue score as part of the QOL registration shows a significant increase for the three groups, however the improvement is minor with age, and between A (14.6) and C (9.1) this improvement is significantly different (p=0.047).
CONCLUSIONS: Elderly patients have the same improvement of their symptomatic status as younger patients. However despite this improvement they have less benefit from CABG regarding to their quality of life and physical activity.

Entities:  

Mesh:

Year:  2008        PMID: 18778947     DOI: 10.1016/j.ejcts.2008.08.003

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

Review 1.  Does coronary artery bypass grafting improve quality of life in elderly patients?

Authors:  Kamran Baig; Leanne Harling; Joseph Papanikitas; Saina Attaran; Hutan Ashrafian; Roberto Casula; Thanos Athanasiou
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-27

2.  Prognostic value of preoperative quality of life on mortality after isolated elective myocardial revascularization.

Authors:  Rutger ter Horst; Athanasios L P Markou; Luc Noyez
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-06-24

Review 3.  Diet and exercise interventions following coronary artery bypass graft surgery: a review and call to action.

Authors:  Garrett N Coyan; K M Reeder; James L Vacek; Garrett N Coyan; K M Reeder; James L Vacek
Journal:  Phys Sportsmed       Date:  2014-05       Impact factor: 2.241

4.  Is a sedentary lifestyle an independent predictor for hospital and early mortality after elective cardiac surgery?

Authors:  L Noyez; I Biemans; M Verkroost; H van Swieten
Journal:  Neth Heart J       Date:  2013-10       Impact factor: 2.380

5.  Quality of life 10 years after cardiac surgery in adults: a long-term follow-up study.

Authors:  Andrea Perrotti; Fiona Ecarnot; Francesco Monaco; Enrica Dorigo; Palmiero Monteleone; Guillaume Besch; Sidney Chocron
Journal:  Health Qual Life Outcomes       Date:  2019-05-22       Impact factor: 3.186

6.  Quality of life after coronary bypass: a multicentre study of routinely collected health data in the Netherlands†.

Authors:  Fredrike Blokzijl; Saskia Houterman; Bart H M van Straten; Edgar Daeter; George J Brandon Bravo Bruinsma; Willem Dieperink; Michiel F Reneman; Frederik Keus; Iwan C C van der Horst; Massimo A Mariani
Journal:  Eur J Cardiothorac Surg       Date:  2019-09-01       Impact factor: 4.191

7.  [Not Available].

Authors:  M Biçer; B Ozdemir; R Işçimen; D Saba; M Yanar; O Tüydeş; I Senkaya; M Cengiz
Journal:  Open Cardiovasc Med J       Date:  2009-04-01

8.  Is quality of life post cardiac surgery overestimated?

Authors:  Luc Noyez
Journal:  Health Qual Life Outcomes       Date:  2014-04-29       Impact factor: 3.186

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.